Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects Clinical research trials and A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects. A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects clinical trial. Human subjects often obtain the finest healthcare possible for their A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects



A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

For Condition: Hypocalcemia
Status: Recruiting
Sponsor(s): Abbott Laboratories ,
Synopsis: A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - ICU patients APACHE III score between 70 - 150 at screening and within 24 hours of enrollment and a whold blood ionized calcium level less than 0.90 mmol/L or corrected whole blook calcium level less than or equal to 7.5 mg/dL. Exclusion Criteria: - Serum creatinine greater than 2.5 mg/dL
Total Enrollment: 45

Location and Contact Information:

Overall Study Official:
JoelMelnick,  Study Director,  Abbott Laboratories

Denver Health Medical Center *Recruiting*
Denver,  Colorado,  80204
United States
Recruiting Ivor  Douglas

Florida Hospital *Recruiting*
Orlando,  Florida,  32803
United States
Recruiting H.B.  Karunaratne 407-894-4474

Outcomes Research Institute *Recruiting*
Hudson,  Florida,  34667
United States
Recruiting Rita  Plyer 727-863-4069

Harborview Medical Center *No longer recruiting*
Seattle,  Washington,  98104
United States
No longer recruiting  

Baylor University Medical Center *Recruiting*
Dallas,  Texas,  75204
United States
Recruiting Renee  Gale 214-820-9907

University of Rochester Medical Center *Recruiting*
Rochester,  New York,  14642
United States
Recruiting David  Kaufman 585-273-1911

University of Chicago *Recruiting*
Chicago,  Illinois,  60637
United States
Recruiting Sharon  Trevino 773-702-4222

Central Baptist Hospital Clinical Research Center *Recruiting*
Lexington,  Kentucky,  40503
United States
Recruiting Lori  Poynter 859-260-6295


Additional Information:
Study ID Numbers:
  M01-395; 
Study Start Date: 
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00053378

Other Hypocalcemia Studies:
1. Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study

2. Resistance to Vitamin D or Parathyroid Hormone

3. Studies with Vitamin D

4. Studies of Elevated Parathyroid Activity

5. A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Related Studies:

Other Hypocalcemia Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Modify your Search

  Other Hypocalcemia Clinical Trials
  Other Washington Clinical Trials
  Other Seattle Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103